Quality of life. 2. Economic analysis of drug therapies.
In 1990, health care expenditures in the United States reached $666.2 billion, 12.2% of the gross domestic product (GDP). It is projected for the year 2000, the USA will spend $1.6 trillion for health care which will be comparable to 16.4% of that year's GDP. As a result of the rapid increase in costs of health care and limited resources available, patients, third-party payers and the government have initiated and implemented more rigid cost control measures. Economic analyses can help ensure the efficient use of health care dollars in areas such as drug therapy. The four methodologies available are cost-benefit analysis, cost-effectiveness analysis, cost-minimization analysis and cost-utility analysis. This article reviews methods and provides examples from the medical literature. These tools can assist care providers in determining which treatments are most cost-effective.
Pham
S V
SV
Department of Pharmacy Practice, College of Pharmacy, University of Arizona, Tucson 85721.
Draugalis
J R
JR
D003362:Cost-Benefit Analysis; D006801:Humans; D011788:Quality of Life